INVESCO Ltd (IVZ)

30.50
+0.40 (1.33%)
NYSE· Last Trade: Jul 22nd, 7:13 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026?fool.com
One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and stronger recent gains.
Via The Motley Fool · July 22, 2026
As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026?fool.com
PJP surged 45% in one year, but VHT's lower costs and higher dividend yield appeal to long-term income investors seeking broad sector exposure.
Via The Motley Fool · July 22, 2026
Shoot for the Stars or Is the Sky the Limit? Invesco Aerospace & Defense ETF Compared to Tema Space Innovators ETFfool.com
PPA targets established defense contractors with lower costs and volatility, while NASA pursues pure-play commercial space companies with higher growth potential.
Via The Motley Fool · July 22, 2026
What History Says About Stocks That Join the Nasdaq-100 and What It Means for SpaceXfool.com
The years ahead will be more important for SpaceX than how it fares in its first few months as a part of the tech-heavy Nasdaq-100 index.
Via The Motley Fool · July 22, 2026
Looking to Recession-Proof Your Portfolio? Consider This ETFfool.com
The Vanguard Consumer Staples ETF and the Invesco Food & Beverage ETF are built to weather recessions, but one is the better choice.
Via The Motley Fool · July 21, 2026
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?fool.com
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.
Via The Motley Fool · July 21, 2026
SLYG vs. RZG: Which Small-Cap Growth ETF Is the Better Buy for Investors?fool.com
RZG has delivered stronger 1-year returns -- but also comes with higher fees. SLYG offers broader diversification with lower costs.
Via The Motley Fool · July 20, 2026
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?fool.com
IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered a 44.90% one-year return.
Via The Motley Fool · July 20, 2026
PJP vs. IYH: Which Healthcare ETF Is the Better Buy?fool.com
PJP delivered a higher return over the past year -- but IYH charges lower fees and pays a higher dividend yield.
Via The Motley Fool · July 20, 2026
Shopping for Portfolio Security? The iShares Consumer Staples ETF (IYK) Outperforms Invesco Food & Beverage (PBJ) in Cost, Yield, and Performancefool.com
IYK delivered 8.3% returns over one year with a 2.5% dividend yield, while maintaining broader sector diversification across household products and tobacco alongside food and beverage stocks.
Via The Motley Fool · July 18, 2026
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?fool.com
IBBQ's concentrated biotech play has delivered a higher one-year return, while IXJ'S diversified global healthcare fund has been much less volatile.
Via The Motley Fool · July 18, 2026
KBWB vs. UYG: Which Financials ETF Is the Better Buy for Investors?fool.com
UYG offers leverage -- with higher fees -- while KBWB's traditional banking focus delivered the stronger one-year return.
Via The Motley Fool · July 17, 2026
FSTA vs. PBJ: Which Consumer Staples ETF Is the Better Buy for Investors?fool.com
FSTA charges lower fees and offers broader diversification across the consumer defensive sector than PBJ.
Via The Motley Fool · July 17, 2026
Prediction: This Growth ETF Will Triple Over the Next 10 Years. Here's the Math.fool.com
This top-performing ETF has lots more growth ahead.
Via The Motley Fool · July 16, 2026
Ways to Invest in Gold: A 2026 Guidetalkmarkets.com
Gold has held its place as a store of value for thousands of years, and in an age of market volatility and currency uncertainty, more investors than ever a
Via Talk Markets · July 16, 2026
If You Invested $100 In Invesco NASDAQ 100 ETF Stock 5 Years Ago, You Would Have This Much Todaybenzinga.com
Invesco NASDAQ 100 ETF (NASDAQ:QQQM) has outperformed the market over the past 5 years by 2.86% on an annualized basis producing an average annual return of 14.68%. Currently, Invesco NASDAQ 100 ETF has a market
Via Benzinga · July 16, 2026
Healthcare Investing in 2026: iShares Global Healthcare ETF Outperforms Invesco Health Care ETFfool.com
IXJ's market-cap weighting and international exposure delivered stronger five-year returns and lower volatility, while offering double the dividend yield.
Via The Motley Fool · July 16, 2026
Can You Build a Retirement Portfolio Using Only ETFs?fool.com
Yep. And you should, if you can.
Via The Motley Fool · July 16, 2026
Invesco Aerospace & Defense ETF vs U.S. Global Jets ETF: Is PPA or JETS the Better Buy in 2026?fool.com
Defense stocks offer steadier returns with lower volatility, while airline operators deliver higher dividend yields but face greater downside risk.
Via The Motley Fool · July 15, 2026
Here’s How Much You Would Have Made Owning Invesco PHLX Semiconductor ETF Stock In The Last 5 Yearsbenzinga.com
Invesco PHLX Semiconductor ETF (NASDAQ:SOXQ) has outperformed the market over the past 5 years by 19.29% on an annualized basis producing an average annual return of 31.15%. Currently, Invesco PHLX Semiconductor ETF has
Via Benzinga · July 15, 2026
Which S&P500 stocks are moving on Wednesday?chartmill.com
Via Chartmill · July 15, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · July 15, 2026
Here’s How Much You Would Have Made Owning Invesco S&P 500 Momentum ETF Stock In The Last 5 Yearsbenzinga.com
Invesco S&P 500 Momentum ETF (NYSE:SPMO) has outperformed the market over the past 5 years by 8.61% on an annualized basis producing an average annual return of 20.46%. Currently, Invesco S&P 500 Momentum ETF
Via Benzinga · July 15, 2026
Morgan Stanley, JPMorgan, Invesco and a Key Tech Stock on CNBC’s ‘Final Trades’benzinga.com
Joshua Brown chooses JPMorgan Chase & Co. as his final trade on CNBC's Halftime Report. Morgan Stanley, Invesco, and NVIDIA also discussed.
Via Benzinga · July 15, 2026
Prediction: Down 4% in a Month, This ETF Will Still Be the Best-Performing Tech ETF This Yearfool.com
Semiconductor stocks still have plenty of runway in front of them.
Via The Motley Fool · July 15, 2026